Business Context and Reporting Period
Company: Can-Fite Biopharma Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Filing Date: March 28, 2019
Reporting Period: The filing incorporates by reference a press release announcing financial results for the year ended December 31, 2018.
Key Financial Metrics
The provided text serves as a cover document incorporating a press release by reference. It does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. The filing text does not provide a clear value for these metrics.
Material Changes
The filing text does not provide specific details on material changes versus prior periods. It only indicates that the full financial results for the 2018 fiscal year are contained in the attached press release (Exhibit 99.1).
Guidance, Outlook, and Risks
The filing incorporates "Forward Looking Statements" from the attached press release by reference but does not reproduce the specific content of the guidance, outlook, management commentary, risks, or contingencies within this text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 28, 2019) for actual financial figures and operational updates.
- Verify the specific details of the "Forward Looking Statements" referenced in the filing.
- Confirm the company's cash position and burn rate, as these are not listed in the cover text.
- Check for any unusual items or contingencies detailed in the full press release.